BIO CEO & Investor Digital Conference 2021
Digital event, February 16-18, 2021
About this conference
At the BIO CEO & Investor Digital Conference, taking place February 16-18, 2021, you will hear key biotech and pharma leaders discuss the most pertinent industry trends, the market outlook, and best practices for executive leadership.
Get the pulse on biotech policy and investment trends, including a premiere of BIO’s newest data on clinical success rates across indications and modalities. Join us for two-days of interactive and on demand sessions from expert speakers including an opening fireside chat with Nasdaq’s CEO Adena Friedman, and then sessions with Dr. Marianne De Backer, EVP of BD&L for Bayer, Spotlight Therapeutics’s CEO Dr. Mary Haak-Frendscho, Merck’s Chief Patient Officer Dr. Julie Gerberding, Dr. Adam Koppel of Bain Capital Life Sciences, Beigene’s CEO John Oyler, and Resilience’s CEO Dr. Rahul Singhvi, among many others.
BIO CEO & Investor Digital Conference 2021 is powered by One-on-One Partnering™
Inova develops the One-on-One Partnering™ platform of BIO CEO & Investor Digital Conference 2021. It’s a smart networking tool to find the right partners and schedule face-to-face meetings at BIO CEO & Investor Digital Conference 2021 and +20 other partnering conferences.
This conference is connected to Inova’s partnering platform
One-on-One Partnering™ is a smart networking tool to schedule face-to-face meetings at partnering conferences. Since BIO CEO & Investor Digital Conference 2021 is using the solution we built, it’s easy for us to connect our products and thus you can easily retrieve all your conference meetings directly in Inova.